Key Points
- Glenbrook Capital Management bought 7,956 shares of Senestech (NASDAQ:SNES) at an average price of $1.72 on Feb. 12, bringing its stake to 618,310 shares (≈$1.06M), part of a recent buying spree that included a 42,739‑share purchase on Feb. 2.
- Senestech is a micro‑cap biotech (market cap ≈ $10.44M) with a 52‑week range of $1.30–$6.24, mixed analyst ratings averaging "Hold" and a reiterated Weiss Ratings "sell (e+)" stance.
Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management bought 7,956 shares of the business's stock in a transaction on Thursday, February 12th. The shares were acquired at an average price of $1.72 per share, for a total transaction of $13,684.32. Following the completion of the purchase, the insider owned 618,310 shares in the company, valued at approximately $1,063,493.20. The trade was a 1.30% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Friday, February 13th, Glenbrook Capital Management purchased 15,390 shares of Senestech stock. The stock was acquired at an average price of $1.89 per share, with a total value of $29,087.10.
- On Wednesday, February 11th, Glenbrook Capital Management purchased 8,000 shares of Senestech stock. The shares were acquired at an average cost of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management acquired 2,884 shares of Senestech stock. The shares were acquired at an average cost of $1.77 per share, for a total transaction of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management acquired 5,685 shares of Senestech stock. The stock was acquired at an average price of $1.82 per share, with a total value of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management bought 42,739 shares of Senestech stock. The shares were bought at an average price of $1.98 per share, for a total transaction of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management purchased 5,399 shares of Senestech stock. The shares were bought at an average cost of $1.87 per share, for a total transaction of $10,096.13.
Senestech Stock Performance
Shares of SNES stock opened at $2.00 on Friday. The company has a quick ratio of 14.73, a current ratio of 15.75 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average price of $2.17 and a 200-day moving average price of $3.42. Senestech, Inc. has a 52 week low of $1.30 and a 52 week high of $6.24. The firm has a market capitalization of $10.44 million, a PE ratio of -0.55 and a beta of 0.21.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Senestech in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold".
Check Out Our Latest Stock Report on SNES
Hedge Funds Weigh In On Senestech
Several institutional investors have recently made changes to their positions in the business. Renaissance Technologies LLC boosted its holdings in shares of Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company's stock worth $306,000 after buying an additional 37,165 shares during the last quarter. DRW Securities LLC raised its position in Senestech by 171.1% in the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company's stock worth $176,000 after acquiring an additional 51,818 shares during the period. Sabby Management LLC purchased a new position in shares of Senestech during the 3rd quarter worth $313,000. Corsair Capital Management L.P. bought a new stake in shares of Senestech during the 2nd quarter valued at $255,000. Finally, Jane Street Group LLC bought a new stake in shares of Senestech during the 2nd quarter valued at $161,000. Institutional investors own 5.19% of the company's stock.
About Senestech
(
Get Free Report)
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company's core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company's flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
